INCR
INC Research Holdings Inc
NASDAQ: INCR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.81
-6.38% today
Updated 2026-04-29
Market cap
$49.15M
P/E ratio
—
P/S ratio
0.55x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $2
Volume
0.0M
WallStSmart proprietary scores
32
out of 100
Grade: F
Strong Sell
Investment rating
3.3
Growth
D4.5
Quality
C2.5
Profitability
F5.0
Valuation
C+1/9
Piotroski F-Score
Weak
0.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$33.56
+4036.06%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $4.48M — positive
+ Debt/equity 0.42x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Altman Z 0.43 — distress zone
- Thin margins at -29.20%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $219.68M | $388.68M | $355.55M | $238.84M | $243.12M |
| Net income | $4.69M | $44.82M | $-61.96M | $-67.80M | $-852000.00 |
| EPS | — | — | — | — | $-0.52 |
| Free cash flow | $10.99M | $31.52M | $-56.25M | $-71.30M | $4.48M |
| Profit margin | 2.13% | 11.53% | -17.43% | -28.38% | -29.20% |
Peer comparison
Smart narrative
INC Research Holdings Inc trades at $0.81. Our Smart Value Score of 32/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 0.43, it sits in the distress. TTM revenue stands at $243.12M. with profit margins at -29.20%.
Frequently asked questions
What is INC Research Holdings Inc's stock price?
INC Research Holdings Inc (INCR) trades at $0.81.
Is INC Research Holdings Inc overvalued?
Smart Value Score 32/100 (Grade F, Strong Sell).
What is the price target of INC Research Holdings Inc (INCR)?
The analyst target price is $33.56, representing +4036.1% upside from the current price of $0.81.
What is INC Research Holdings Inc's revenue?
TTM revenue is $243.12M.
Piotroski F-Score?
1/9 — weak financial health.
Altman Z-Score?
0.43 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.55x
ROE-16.70%
Beta0.33
50D MA$0.80
200D MA$1.23
Shares out0.05B
Float0.04B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—